# Enveric Biosciences, Inc.: Form 10-K/A for the period ended Dec 31, 2022

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 10-K/A
- Filed: 2023-06-09
- Accepted by EDGAR: Jun 8, 2023, 18:49 ET
- Period: 2022-12-31
- Accession: 0001493152-23-020625
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000149315223020625/form10-ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000149315223020625/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2022-01-01 to 2022-12-31 | $8.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2022-01-01 to 2022-12-31 | −$27.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2022-01-01 to 2022-12-31 | $5.2k | us-gaap:InterestExpense |
| Income tax | 12 months, 2022-01-01 to 2022-12-31 | −$1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2022-01-01 to 2022-12-31 | −$18.5m | us-gaap:NetIncomeLoss |
| Basic EPS | 12 months, 2022-01-01 to 2022-12-31 | −$13.00 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 12 months, 2022-01-01 to 2022-12-31 | −$17.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-01-01 to 2022-12-31 | $584.2k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-12-31 | $17.7m | us-gaap:Cash |
| Current assets | at 2022-12-31 | $18.4m | us-gaap:AssetsCurrent |
| Total assets | at 2022-12-31 | $19.6m | us-gaap:Assets |
| Current liabilities | at 2022-12-31 | $4.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-12-31 | $4.0m | us-gaap:Liabilities |
| Shareholders' equity | at 2022-12-31 | $14.7m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000149315223020625/form10-ka.htm

Filed Jun 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-020625. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
